Outliers in the number of cases of influenza-like illness (ILI) that tested negative for influenza were present in global influenza surveillance networks early in the COVID-19 pandemic, an average of 13.3 weeks before the first reported COVID-19 peaks in 16 of the 28 countries included in a new study publishing July 19th in PLOS Medicine by Natalie Cobb of University of Washington, US, and colleagues.
Credit: Martin Sanchez, Unsplash (CC0, https://creativecommons.org/publicdomain/zero/1.0/)
Outliers in the number of cases of influenza-like illness (ILI) that tested negative for influenza were present in global influenza surveillance networks early in the COVID-19 pandemic, an average of 13.3 weeks before the first reported COVID-19 peaks in 16 of the 28 countries included in a new study publishing July 19th in PLOS Medicine by Natalie Cobb of University of Washington, US, and colleagues.
Surveillance systems are important in detecting changes in disease patterns and can act as early warning systems for emerging disease outbreaks. The WHO Global Influenza Surveillance and Response System (GISRS) is a network of centers and laboratories across 123 WHO member states which collect respiratory specimens for influenza testing. Data from these labs are made available through FluNet, a web-based tool for monitoring influenza trends.
In the new study, Cobb and colleagues evaluated outliers in influenza-negative ILI in 2020 compared to trends over the previous five years among 28 countries with established ILI surveillance and a high incidence of COVID-19. The team found that in 16 countries, outliers in this dataset preceded the first reported COVID-19 peaks with an average lag time of 13.3 weeks. The earliest outliers occurred during the week of January 13, 2020 in Peru, the Philippines, Poland, and Spain. In the United States and the United Kingdom, outliers in the dataset were detectable the week of March 9, 2020, 4 to 6 weeks before the first week of the reported COVID-19 peak. Lag times of over 20 weeks were seen in some countries. The researchers say that these outliers may represent undetected spread of COVID-19 in early 2020, although a limitation is that it was not possible to evaluate SAR-CoV-2 positivity during this time.
The findings “highlight the importance of strengthening routine disease surveillance networks to enhance the ability to identify novel diseases and inform public health responses on a global scale,” the researchers say.
Cobb adds, “In the first year of the COVID-19 pandemic, we found increases in cases of non-influenza respiratory illness before the first reported major outbreaks of COVID-19, suggesting COVID-19 may have spread much faster than initially reported globally. We propose using automated tracking of respiratory illness in existing surveillance networks to identify new outbreaks in real time as a type of early warning system.”
#####
In your coverage, please use this URL to provide access to the freely available paper in PLOS Medicine:
http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1004035
Citation: Cobb NL, Collier S, Attia EF, Augusto O, West TE, Wagenaar BH (2022) Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015–2020. PLoS Med 19(7): e1004035. https://doi.org/10.1371/journal.pmed.1004035
Author Countries: United States
Funding: NLC received support from the National Heart, Lung, and Blood Institute (NHLBI) grant T32 HL007287. SC was supported by the Fogarty International Center and National Cancer Institute (NCI) of the National Institutes of Health under grant D43TW009345-09S7 awarded to the Northern Pacific Global Health Fellows Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Journal
PLoS Medicine
DOI
10.1371/journal.pmed.1004035
Method of Research
Observational study
Subject of Research
People
COI Statement
Competing interests: I have read the journal’s policy and the authors of this manuscript have the following competing interests: TEW: Funding for studies of respiratory infection from NIH and CDC. The other Authors have declared no competing interests.